118
Views
0
CrossRef citations to date
0
Altmetric
Reviews

The Association of Empirical Dietary Index for Hyperinsulinemia with the Risk of Cancer and Cancer Mortality: A Meta-analysis of Observational Studies

, , , &
Pages 1399-1412 | Received 06 Jul 2022, Accepted 05 Mar 2023, Published online: 08 May 2023

References

  • Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017;18(12):1579–89. doi: 10.1016/s1470-2045(17)30677-0.
  • Ferlay JE, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. 2020.
  • Gallagher EJ, LeRoith D. Hyperinsulinaemia in cancer. Nat Rev Cancer. 2020;20(11):629–44. doi: 10.1038/s41568-020-0295-5.
  • Vigneri R, Sciacca L, Vigneri P. Rethinking the relationship between insulin and cancer. Trends Endocrinol Metab. 2020;31(8):551–60. doi: 10.1016/j.tem.2020.05.004.
  • Belfiore A, Malaguarnera R. Insulin receptor and cancer. Endocr Relat Cancer. 2011;18(4):R125–47. doi: 10.1530/erc-11-0074.
  • Vigneri R, Goldfine ID, Frittitta L. Insulin, insulin receptors, and cancer. J Endocrinol Invest. 2016;39(12):1365–76. doi: 10.1007/s40618-016-0508-7.
  • Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2101–9. doi: 10.1158/1055-9965.epi-07-0182.
  • Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. Jama. 2005;294(22):2872–8. doi: 10.1001/jama.294.22.2872.
  • Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO, Chen JR, Pan XY, Shrubsole M, Zheng W. Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1207–11.
  • Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004;96(7):546–53. doi: 10.1093/jnci/djh082.
  • Yoon YS, Keum N, Zhang X, Cho E, Giovannucci EL. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis. Metabolism. 2015;64(10):1324–33. doi: 10.1016/j.metabol.2015.06.013.
  • Hammarsten J, Högstedt B. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer. 2005;41(18):2887–95. doi: 10.1016/j.ejca.2005.09.003.
  • Tsujimoto T, Kajio H, Sugiyama T. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. Int J Cancer. 2017;141(1):102–11. doi: 10.1002/ijc.30729.
  • Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, et al. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol. 2012;49(6):421–8. doi: 10.1007/s00592-011-0361-2.
  • Gannon MC, Nuttall FQ, Neil BJ, Westphal SA. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 1988;37(11):1081–8. doi: 10.1016/0026-0495(88)90072-8.
  • Tabung FK, Wang W, Fung TT, Hu FB, Smith-Warner SA, Chavarro JE, Fuchs CS, Willett WC, Giovannucci EL. Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. Br J Nutr. 2016;116(10):1–12. doi: 10.1017/S0007114516003755.
  • Aroke D, Folefac E, Shi N, Jin Q, Clinton SK, Tabung FK. Inflammatory and insulinemic dietary patterns: influence on circulating biomarkers and prostate cancer risk. Cancer Prev Res (Phila). 2020;13(10):841–52. doi: 10.1158/1940-6207.capr-20-0236.
  • Cheng E, Zhang S, Ou F-S, Mullen B, Ng K, Saltz LB, Niedzwiecki D, Mayer RJ, Mowat RB, Whittom R, et al. The diet of higher insulinemic potential is not associated with worse survival in patients with stage III colon cancer (alliance). Cancer Epidemiol Biomarkers Prev. 2020;29(8):1692–5. doi: 10.1158/1055-9965.epi-19-1454.
  • Fu BC, Tabung FK, Pernar CH, Wang W, Gonzalez-Feliciano AG, Chowdhury-Paulino IM, Clinton SK, Folefac E, Song M, Kibel AS, et al. Insulinemic and inflammatory dietary patterns and risk of prostate cancer. Eur Urol. 2021;79(3):405–12. doi: 10.1016/j.eururo.2020.12.030.
  • Jin Q, Hart PA, Shi N, Joseph JJ, Donneyong M, Conwell DL, Clinton SK, Cruz-Monserrate Z, Brasky TM, Tinker LF, et al. Dietary patterns of insulinemia, inflammation and glycemia, and pancreatic cancer risk: Findings from the women’s health initiative. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1229–40. doi: 10.1158/1055-9965.epi-20-1478.
  • Lee DH, Fung TT, Tabung FK, Colditz GA, Ghobrial IM, Rosner BA, Giovannucci EL, Birmann BM. Dietary pattern and risk of multiple myeloma in two large prospective U.S. cohort studies. JNCI Cancer Spectr. 2019;3(2):pkz025. doi: 10.1093/jncics/pkz025.
  • Tabung FK, Wang W, Fung TT, Smith-Warner SA, Keum N, Wu K, Fuchs CS, Hu FB, Giovannucci EL. Association of dietary insulinemic potential and colorectal cancer risk in men and women. Am J Clin Nutr. 2018;108(2):363–70. doi: 10.1093/ajcn/nqy093.
  • Wang W, Fung TT, Wang M, Smith-Warner SA, Giovannucci EL, Tabung FK. Association of the insulinemic potential of diet and lifestyle with risk of digestive system cancers in men and women. JNCI Cancer Spectr. 2018;2(4):pky080. doi: 10.1093/jncics/pky080.
  • Yang W, Sui J, Zhao L, Ma Y, Tabung FK, Simon TG, Lee DH, Zeng X, Nguyen LH, Meyerhardt JA, et al. Association of inflammatory and insulinemic potential of diet and lifestyle with risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30(4):789–96. doi: 10.1158/1055-9965.epi-20-1329.
  • Yue Y, Hur J, Cao Y, Tabung FK, Wang M, Wu K, Song M, Zhang X, Liu Y, Meyerhardt JA, et al. Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women. Ann Oncol. 2021;32(6):778–86. doi: 10.1016/j.annonc.2021.03.200.
  • Romanos-Nanclares A, Tabung FK, Willett WC, Rosner B, Holmes MD, Chen WY, Tamimi RM, Eliassen AH. Insulinemic potential of diet and risk of total and subtypes of breast cancer among U.S. females. Am J Clin Nutr. 2022;116(6):1530–9. doi: 10.1093/ajcn/nqac284.
  • Lee DH, Fung TT, Tabung FK, Marinac CR, Devore EE, Rosner BA, Ghobrial IM, Colditz GA, Giovannucci EL, Birmann BM, et al. Prediagnosis dietary pattern and survival in patients with multiple myeloma. Int J Cancer. 2020;147(7):1823–30. doi: 10.1002/ijc.32928.
  • Tabung FK, Noonan A, Lee DH, Song M, Clinton SK, Spakowicz D, Wu K, Cheng E, Meyerhardt JA, Fuchs CS, et al. Post-diagnosis dietary insulinemic potential and survival outcomes among colorectal cancer patients. BMC Cancer. 2020;20(1):817. doi: 10.1186/s12885-020-07288-0.
  • Wan Y, Tabung FK, Lee DH, Fung TT, Willett WC, Giovannucci EL. Dietary insulinemic potential and risk of total and cause-specific mortality in the nurses’ health study and the health professionals follow-up study. Diabetes Care. 2022;45(2):451–9. doi: 10.2337/dc21-1530.
  • Wang Y, Chen B, Zhang J, Li H, Zeng X, Zhang Z, Zhu Y, Li X, Hu A, Zhao Q, Yang W. Diets with higher insulinaemic potential are associated with increased risk of overall and cardiovascular disease-specific mortality. Br J Nutr. 2021;128(10):1–10. doi: 10.1017/s0007114521004815.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9. doi: 10.1016/j.jclinepi.2007.11.008.
  • Wells GA, Wells G, Shea B, Shea B, O’Connell D, Peterson J, Welch, Losos M, Tugwell P, Wells Ga Sb, Zello G, Petersen J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2014.
  • Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www cochrane-handbook org., 2011.
  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statist Med. 2002;21(11):1539–58. 10.1002/sim.1186
  • Bao J, de Jong V, Atkinson F, Petocz P, Brand-Miller JC. Food insulin index: physiologic basis for predicting insulin demand evoked by composite meals. Am J Clin Nutr. 2009;90(4):986–92. doi: 10.3945/ajcn.2009.27720.
  • Teymoori F, Mokhtari E, Bahrami A, Farhadnejad H, Azadi M, Nazarzadeh M, Vafa M. The association of dietary insulin load and index with the risk of cancer and cancer mortality: a systematic review and meta-analysis. J Diabetes Metab Disord. 2022;21(1):1105–18. doi: 10.1007/s40200-022-01013-3.
  • Anjom-Shoae J, Shayanfar M, Mohammad-Shirazi M, Sadeghi O, Sharifi G, Siassi F, Esmaillzadeh A. Dietary insulin index and insulin load in relation to glioma: Findings from a case-control study. Nutr Neurosci. 2021;24(5):354–62. doi: 10.1080/1028415x.2019.1631594.
  • Prescott J, Bao Y, Viswanathan AN, Giovannucci EL, Hankinson SE, De Vivo I. Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1512–20. doi: 10.1158/1055-9965.Epi-14-0157.
  • Chen L, Li L, Wang Y, Li P, Luo L, Yang B, Wang H, Chen M. Circulating C-peptide level is a predictive factor for colorectal neoplasia: evidence from the meta-analysis of prospective studies. Cancer Causes Control. 2013;24(10):1837–47. doi: 10.1007/s10552-013-0261-6.
  • Guo Z-L, Weng X-T, Chan F-L, Gong L-L, Xiang S-T, Gan S, Gu C-M, Wang S-S. Serum C-peptide concentration and prostate cancer: a meta-analysis of observational studies. Medicine (Baltimore). 2018;97(31):e11771. doi: 10.1097/md.0000000000011771.
  • Lovejoy JC, Sainsbury A, Stock Conference 2008 Working Group. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev. 2009;10(2):154–67. doi: 10.1111/j.1467-789X.2008.00529.x.
  • Marks GC, Hughes MC, van der Pols JC. Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. J Nutr. 2006;136(2):459–65. doi: 10.1093/jn/136.2.459.
  • O’Doherty Jensen K, Holm L. Preferences, quantities and concerns: sociocultural perspectives on the gendered consumption of foods. Eur J Clin Nutr. 1999;53(5):351–9. doi: 10.1038/sj.ejcn.1600767.
  • Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol. 2001;154(12):1089–99. doi: 10.1093/aje/154.12.1089.
  • Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Andò S, Sisci D. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets. 2008;8(7):597–610. doi: 10.2174/156800908786241104.
  • Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem. 2000;275(24):18447–53. doi: 10.1074/jbc.M910345199.
  • Wong VW-S, Yu J, Cheng AS-L, Wong GL-H, Chan H-Y, Chu ES-H, Ng EK-O, Chan FK-L, Sung JJ-Y, Chan HL-Y. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009;124(12):2766–70. doi: 10.1002/ijc.24281.
  • Kira S, Ito C, Fujikawa R, Misumi M. Increased cancer mortality among Japanese individuals with hyperinsulinemia. Metabol Open. 2020;7:100048. doi: 10.1016/j.metop.2020.100048.
  • Wargny M, Balkau B, Lange C, Charles M-A, Giral P, Simon D. Association of fasting serum insulin and cancer mortality in a healthy population – 28-year follow-up of the French TELECOM Study. Diabetes Metab. 2018;44(1):30–7. doi: 10.1016/j.diabet.2017.03.006.
  • Kim NH, Chang Y, Lee SR, Ryu S, Kim HJ. Glycemic status, insulin resistance, and risk of pancreatic cancer mortality in individuals with and without diabetes. Am J Gastroenterol. 2020;115(11):1840–8. doi: 10.14309/ajg.0000000000000956.
  • Otten J, Tavelin B, Söderberg S, Rolandsson O. Fasting C-peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality. Diabetes Metab Res Rev. 2022;38(3):e3512. doi: 10.1002/dmrr.3512.
  • Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008;9(11):1039–47. doi: 10.1371/journal.pone.0055625. 10.1016/S1470-2045(08)70235-3
  • Hsu CN, Chang CH, Lin YS, Lin JW, Caffrey JL. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed ­diabetes. Diabetes Metab Res Rev. 2013;8(2):e55625. doi: 10.1002/dmrr.3512.
  • Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GYF, Xue X, Anderson GL, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101(1):48–60. doi: 10.1093/jnci/djn415.
  • Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012;19(5):F27–45. doi: 10.1530/erc-11-0374.
  • Parekh N, Lin Y, Hayes RB, Albu JB, Lu-Yao GL. Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control. 2010;21(4):631–42. doi: 10.1007/s10552-009-9492-y.
  • Kruse M, Seltmann A, Gögebakan Ö, Osterhoff M, Pfeiffer A. Insulin induces an inflammatory cytokine response in human and murine adipocytes in vitro via the PI3Kinase/Akt-pathway. Exp Clin Endocrinol Diabetes. 2013;121(03):P37. 10.1055/s-0033-1336676
  • Il’yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2413–8. doi: 10.1158/1055-9965.epi-05-0316.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.